These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11560209)

  • 1. Correlation between serum hyaluronan and disease activity and severity in Thai patients with rheumatoid arthritis.
    Louthrenoo W; Kongtawelert P; Sivasomboon C; Sukitawut W
    J Med Assoc Thai; 2001 May; 84(5):622-7. PubMed ID: 11560209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity.
    Emlen W; Niebur J; Flanders G; Rutledge J
    J Rheumatol; 1996 Jun; 23(6):974-8. PubMed ID: 8782125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between serum hyaluronic acid level and disease activity in early rheumatoid arthritis.
    Majeed M; McQueen F; Yeoman S; McLean L
    Ann Rheum Dis; 2004 Sep; 63(9):1166-8. PubMed ID: 15308530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SHAP-HA complex in sera from patients with rheumatoid arthritis and osteoarthritis.
    Kida D; Yoneda M; Miyaura S; Ishimaru T; Yoshida Y; Ito T; Ishiguro N; Iwata H; Kimata K
    J Rheumatol; 1999 Jun; 26(6):1230-8. PubMed ID: 10381035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma monocyte chemoattractant protein 1 is a marker for joint inflammation in rheumatoid arthritis.
    Ellingsen T; Buus A; Stengaard-Pedersen K
    J Rheumatol; 2001 Jan; 28(1):41-6. PubMed ID: 11196541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of hyaluronic acid indicate the severity of joint symptoms in patients with systemic and polyarticular juvenile rheumatoid arthritis.
    Takei S; Imanaka H; Maeno N; Shigemori M; Masuda K; Hokonohara M; Miyata K
    J Rheumatol; 1996 Nov; 23(11):1956-62. PubMed ID: 8923375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum concentration of hyaluronic acid in healthy populations and patients with rheumatoid arthritis--relationship to clinical disease activity of RA].
    Yoshinoya S; Mizoguchi Y; Hashimoto Y; Yamada A; Uchida S; Taniguchi A; Nishioka K; Miyamoto T
    Ryumachi; 1991 Aug; 31(4):381-90. PubMed ID: 1948454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum hyaluronic acid levels are elevated in arthritis patients, but normal and not associated with clinical data in patients with fibromyalgia syndrome.
    Werle E; Jäkel HP; Müller A; Fischer H; Fiehn W; Eich W
    Clin Lab; 2005; 51(1-2):11-9. PubMed ID: 15719700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.
    Park MC; Chung SJ; Park YB; Lee SK
    Scand J Rheumatol; 2008; 37(3):173-8. PubMed ID: 18465450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of antioxidant proteins and soluble intercellular adhesion molecule-1 in serum of patients with rheumatoid arthritis.
    Cogalgil S; Taysi S
    Ann Clin Lab Sci; 2002; 32(3):264-70. PubMed ID: 12175089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum hyaluronic acid and aminoterminal procollagen III peptide in inflammatory and degenerative joint diseases].
    Seibel MJ; Raimann S; Seglias J; Lautenschläger J; Müller W
    Z Rheumatol; 1988; 47(2):98-106. PubMed ID: 3388993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis.
    Klimiuk PA; Fiedorczyk M; Sierakowski S; Chwiecko J
    Scand J Rheumatol; 2007; 36(5):345-50. PubMed ID: 17963163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P in the serum of patients with rheumatoid arthritis.
    Anichini M; Cesaretti S; Lepori M; Maddali Bongi S; Maresca M; Zoppi M
    Rev Rhum Engl Ed; 1997 Jan; 64(1):18-21. PubMed ID: 9051855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis.
    Lard LR; Roep BO; Toes RE; Huizinga TW
    J Rheumatol; 2004 Jan; 31(1):35-9. PubMed ID: 14705216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination drug strategy in recent-onset rheumatoid arthritis suppresses collagen I degradation and is associated with retardation of radiological progression.
    Hakala M; Risteli J; Aman S; Kautiainen H; Korpela M; Hannonen P; Leirisalo-Repo M; Laasonen L; Paimela L; Möttönen T;
    Scand J Rheumatol; 2008; 37(2):90-3. PubMed ID: 18415764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
    Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
    Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis.
    Yildirim K; Karatay S; Melikoglu MA; Gureser G; Ugur M; Senel K
    Ann Clin Lab Sci; 2004; 34(4):423-6. PubMed ID: 15648784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis.
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Gindzienska-Sieskiewicz E; Chwiecko J
    J Rheumatol; 2006 Aug; 33(8):1523-9. PubMed ID: 16881109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
    Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
    J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.